Aspirin is clinically effective in chemoprevention of colorectal neoplasia: Point

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 7, 2008, Pages 1558-1563

  Leshno, Moshe ^a,c   Moshkowitz, Menachem ^b,c   Arber, Nadir ^b,c,d   Sandler, Robert S ^e  

^a Reckanati School of Business   (Israel)

^b Integrated Cancer Prevention Center   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; LYSINE ACETYLSALICYLATE; PLACEBO; NONSTEROID ANTIINFLAMMATORY AGENT;

ADENOMA; BLEEDING; CANCER INCIDENCE; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CANCER SCREENING; CARDIOVASCULAR DISEASE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL TUMOR; CONTROLLED CLINICAL TRIAL; DRUG DOSE COMPARISON; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; HUMAN; ISCHEMIC HEART DISEASE; LOW DRUG DOSE; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; ULCER; METHODOLOGY; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CHEMOPREVENTION; COLORECTAL NEOPLASMS; HUMANS; TREATMENT OUTCOME;

EID: 53549093069     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-0259     Document Type: Review

References (0)